Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$5,098,193
+$220,638 QoQ
Shares Held
20,074
+0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.29%
of 13F equity value
Holder Rank
#1,604
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argent Advisors, Inc. holds $22,940,677 across 9 Drug Manufacturers - General names. JNJ ranks #2 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,391 | $5,266,697 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
20,074 | $5,098,193 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,547 | $3,154,289 | |
| 4 | GSK |
GSK plc
|
51,943 | $2,722,852 | |
| 5 | PFE |
Pfizer Inc
|
109,643 | $2,640,203 | |
| 6 | AMGN |
Amgen Inc
|
4,586 | $1,660,682 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,701 | $1,478,304 | |
| 8 | ABBV |
AbbVie Inc.
|
2,592 | $652,250 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,098,193 | 20,074 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $4,877,555 | 19,954 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $4,219,089 | 20,387 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,776,449 | 20,367 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,943,034 | 19,267 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,001,538 | 18,099 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,486,162 | 17,191 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,728,604 | 16,837 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,388,546 | 16,342 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,446,882 | 15,468 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,349,846 | 14,992 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,916,107 | 18,723 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,521,934 | 21,278 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $3,250,660 | 20,972 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $3,603,130 | 20,397 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $3,391,190 | 20,759 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,646,587 | 20,543 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,504,191 | 19,772 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $3,174,032 | 18,554 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,911,845 | 18,030 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,680,978 | 16,274 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $2,618,259 | 15,931 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $2,674,358 | 16,993 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,326,547 | 15,627 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $2,133,075 | 15,168 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,928,528 | 14,707 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||